Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 5,058,000 | 5,045,000 | 5,001,000 | 5,430,000 | 5,059,000 |
| Cost of Goods | 2,249,000 | 2,384,000 | 2,304,000 | 2,536,000 | 2,429,000 |
| Gross Profit | 2,809,000 | 2,661,000 | 2,697,000 | 2,894,000 | 2,630,000 |
| Operating Expenses | 1,533,000 | 1,593,000 | 1,668,000 | 1,874,000 | 1,663,000 |
| Operating Income | 1,276,000 | 1,068,000 | 1,029,000 | 1,020,000 | 967,000 |
| Other Income | -253,000 | -221,000 | -146,000 | -529,000 | -249,000 |
| Pre-tax Income | 1,023,000 | 847,000 | 883,000 | 491,000 | 718,000 |
| Income Tax | 160,000 | 102,000 | 143,000 | 114,000 | 12,000 |
| Net Income Continuous | 863,000 | 745,000 | 740,000 | 377,000 | 706,000 |
| Minority Interests | -13,000 | -3,000 | -4,000 | -3,000 | -5,000 |
| Net Income | $876,000 | $748,000 | $744,000 | $380,000 | $711,000 |
| EPS Basic Total Ops | 1.02 | 0.88 | 0.88 | 0.44 | 0.84 |
| EPS Basic Continuous Ops | 1.01 | 0.87 | 0.87 | 0.45 | 0.84 |
| EPS Diluted Total Ops | 1.02 | 0.87 | 0.87 | 0.44 | 0.84 |
| EPS Diluted Continuous Ops | 1.00 | 0.87 | 0.87 | 0.45 | 0.83 |
| EBITDA(a) | $1,637,000 | $1,442,000 | $1,433,000 | $1,456,000 | $1,386,000 |